G Venkatasubramanian. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antipsychotic Agents/adverse effectsAntipsychotic Agents/therapeutic useApoptosis/drug effectsCentral Nervous System/drug effectsCentral Nervous System/metabolismHumansLeptin/metabolismMetabolic Syndrome/chemically inducedMetabolic Syndrome/metabolismNeuroprotective Agents/metabolismNeuroprotective Agents/pharmacologyPsychotic Disorders/drug therapyPsychotic Disorders/metabolismPsychotic Disorders/physiopathologySchizophrenia/drug therapyWeight Gain/drug effects
Substances： See more » Antipsychotic AgentsLeptinNeuroprotective Agents
Year: 2009 PMID： 19489746 DOI： 10.1111/j.1600-0447.2009.01415.x
Source DB: PubMed Journal: Acta Psychiatr Scand ISSN： 0001-690X Impact factor: 6.392